🔗 Share this article

Given that America proceeds with historic revisions to its vaccine schedules, a particular individual has surfaced unexpectedly: Tracy Beth Høeg, an American of Danish descent sports physician and epidemiologist who initially gained attention by expressing skepticism about COVID-19 vaccinations throughout the pandemic and has zeroed in on possible deaths following Covid immunization in her recent tenure at the US Food and Drug Administration (FDA).

Proposed Changes to Pediatric Immunization Program

Agency leaders planned to unveil major changes to the childhood immunization program earlier this month, aligning the US with Denmark’s vaccine program, it is understood – a substantial departure that would put the US at odds with a large portion of the world with insufficient data for improved outcomes. The announcement has been pushed back until the new year.

In place of the top vaccines chief, Dr. Høeg is set to speak at the gathering. She was just designated interim head of the FDA’s CDER, the fifth person to lead the office this calendar year.

A Shift at the Agency

Høeg's temporary position may indicate a strengthened alliance between the drug and biologics divisions as Høeg and Dr. Prasad consolidate power at the agency – and it signals a renewed priority upon reevaluating already-approved immunizations at the FDA.

Høeg has frequently advocated for ending some childhood immunization guidelines in the US to become more like Denmark, a society with universal health coverage and a number of inhabitants about the size of the state of Wisconsin.

To date public appearances, she has persisted in emphasizing on vaccines – usually the purview of Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than drug regulation.

Doubts Over Background

Høeg has no apparent background in pharmaceutical research, regulation or management, which has been standard for former directors of the biologics center. She has been employed at the FDA as a key advisor to the FDA chief and CBER since spring.

“She appears not to have the requisite experience” for leading the pharmaceutical oversight division, said Dr. Jonathan Howard. “She’s never run a clinical trial. She lacks experience in managing a major agency. She lacks background in pharmaceutical oversight.”

Previous commissioners of CBER would “be deeply familiar with laws and regulations and the science of drug development”, said Janet Woodcock. “Objectively, she has not acquired the kind of background that previous people who ran the center have had.”

This division has an vast workload at the agency, the former commissioner emphasized.

“Many people just focuses on the innovative therapies, but the generic program approves numerous generic medications. There’s a biosimilars division, non-prescription drug unit and more, and each of these need to be looked after,” Woodcock said. “The thing you don’t keep your eye on, that is the part that I always told people is going to cause problems.”

Additionally, a substantial administrative element to the position, which oversees more than 5,000 employees. “It’s a enormous administrative position, if you perform it correctly,” the former official said.

Official Statement and Contentious Initiatives

When asked about concerns about Dr. Høeg's fitness for the role and whether this assignment signifies increased cooperation among FDA leaders on vaccines, a press secretary stated that the “inquiries stem from flawed assumptions”.

“Her experience is consistent with the functions of her role,” the spokesperson said, noting the months Høeg spent guiding the agency head on “medication safety and approval science, including computational safety modeling and shot safety tracking”.

As acting director, Dr. Høeg inherits the agency head's new fast-track approval initiative, a disputed one-day drug-approval program that allegedly concerned her former heads. “By what process are these therapies being chosen for this expedited pathway? Who makes the choices?” Dr. Howard questioned. “There’s a lot of confidentiality happening at the agency right now.”

In general, he remarked, “the Food and Drug Administration looks to be trending towards laxer oversight of most medications, except for vaccines.”

Documented History on Vaccines

Concerning vaccines, Dr. Høeg has a more established, if concerning, track record, Howard observe. She published a research paper using non-validated volunteer-provided data to assess the frequency of myocarditis after Covid immunization. She consulted for the Florida top health official Dr. Joseph Ladapo, who allegedly have modified findings to indicate Covid vaccinations are more dangerous than they are.

Part of her “desired changes” for the current government featured changing rules for new vaccines and discontinuing “optional” vaccines, she stated following the vote on a online show. At the agency, Høeg has according to sources proposed barring teenage boys from getting Covid vaccinations.

“She is an thorough true believer who begins with her conclusions and reverse-engineers to accommodate the evidence in a highly deceptive, untruthful manner,” Howard argued.

Taking Control and a “Campaign of Retribution”

Dr. Høeg aligned with other skeptics, {like|